3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
50
Carcinoma, Non-Small-Cell Lung
26
Squamous Cell Carcinoma of Head and Neck
25
Head and Neck Neoplasms
12
Neoplasm Metastasis
11
Neoplasms
10
Colonic Neoplasms
10
Rectal Neoplasms
9
Pancreatic Neoplasms
9
Lung Neoplasms
9
Mouth Neoplasms
6
Carcinoma, Squamous Cell
6
Carcinoma
6
Laryngeal Neoplasms
5
Hypopharyngeal Neoplasms
5
Oropharyngeal Neoplasms
4
Thyroid Neoplasms
3
Solid Tumors
3
Ovarian Neoplasms
3
Gastrointestinal Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Pancreatic Ductal
3
Breast Neoplasms
3
Sarcoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Laryngeal Diseases
2
mCRC
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
tislelizumab
3
pembrolizumab
2
toripalimab
1
tazemetostat
1
sintilimab
1
osimertinib
1
enzalutamide
1
envafolimab
1
encorafenib
1
binimetinib
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Ultrasonography
1
Specimen Handling
1
Radiotherapy
1
Oxaliplatin
1
Off-Label Use
1
Leucovorin
1
Injections
1
Indocyanine Green
1
Immune Checkpoint Inhibitors
1
Histocompatibility Testing
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
Cetuximab
×
90 days
×
Clear all
No trials found.